Cravath, Swaine & Moore

Andrew M. Wark

Deals
2
Latest
Aug 2026

Firm

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Andrew M. Wark was named on, most recent first
Aug 2026 TYRVAYA (varenicline solution) nasal spray 0.03 mg ViatrisHarrowAsset saleLegal adviser to Viatris (seller)Announced30.0Pharma+1Harrow acquisition of TYRVAYA (varenicline solution) nasal spray 0.03 mg
Jul 2026 BOX Exchange –TMX GroupMergerLegal adviser to TMX Group (acquirer)Announced2,300.0Exchanges and market infrastructure+1Members Exchange (MEMX) and BOX Exchange merger

Deals where Andrew M. Wark is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.